← Back to Search

Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise

Phase < 1
Waitlist Available
Research Sponsored by Jamie Burr
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention (<2 hours)
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine the effects of different cannabis compositions on cardiovascular risks at rest and during exercise.

Eligible Conditions
  • Cardiovascular Risk
  • Cannabis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention (<2 hours)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention (<2 hours) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Aortic Stiffness From Baseline Following Cannabis Consumption
Change in Brachial Artery Vascular Function From Baseline Following Cannabis Consumption
Change in Cardiac Function From Baseline Following Cannabis Consumption
+1 more
Secondary study objectives
Diastolic Blood Pressure
Exercise Capacity
Heart Rate
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: High THC, VaporizedExperimental Treatment1 Intervention
Group II: High THC, SmokedExperimental Treatment1 Intervention
Group III: High CBD, VaporizedExperimental Treatment1 Intervention
Group IV: High CBD, SmokedExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medical Cannabis
Not yet FDA approved

Find a Location

Who is running the clinical trial?

Jamie BurrLead Sponsor
~5 spots leftby Dec 2025